Relmada Therapeutics, Inc.

NASDAQ:RLMD

Biotechnology

Healthcare
$3.11 -0.97%

-$0.06 today

Market cap
$331.82M
Beta
0.39
P/E (TTM)
-9.6
EPS (TTM)
-$0.68
52W Low $0.52High $8.00

Volume 1.71M

Average 1.24M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$59.10M

FY 2025 · Annual

Net Income

-$57.39M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development90.62M113.32M54.81M46.18M744.56K
Selling, General & Admin35.08M47.93M48.9M37.72M311.9K
Operating Expenses125.7M161.25M103.7M83.89M59.1M
Depreciation & Amortization1.26K2K103.7M00
EBITDA(125.75M)(157.04M)4.91M(79.98M)(57.39M)
EBITDA Margin—————
Operating Income(125.7M)(161.25M)(103.7M)(83.89M)(59.1M)
Operating Margin—————
Interest Income1.2M2.66M5.15M3.53M1.4M
Interest Expense00000
Other Income / Expenses(48.32K)4.21M4.91M3.91M1.72M
Income Before Tax(125.75M)(157.04M)(98.79M)(79.98M)(57.39M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(125.75M)(157.04M)(98.79M)(79.98M)(57.39M)
Net Margin—————
EPS (Basic)(7.16)(5.30)(3.28)(2.65)(1.45)
EPS (Diluted)(7.16)(5.30)(3.28)(2.65)(1.45)
Weighted Avg Shares17.55M29.63M30.1M30.16M39.48M
Weighted Avg Shares (Diluted)17.55M29.63M30.1M30.16M39.48M

RLMD Earnings Waterfall · TTM

NASDAQ:RLMD · Revenue to Net Income

Key Ratios

EPS$-1.11
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-3.6
P/S Ratio0.0

Analysis

$0 of revenue converted into -$58.9M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.11, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
4Statement of changes in beneficial ownershipSep 11, 2026
4Statement of changes in beneficial ownershipSep 11, 2026
8-KCurrent reportSep 8, 2026

How much revenue does RLMD generate?

Relmada Therapeutics, Inc. (RLMD) reported $0.00 of revenue in fiscal 2025.

Is RLMD profitable?

Relmada Therapeutics, Inc. (RLMD) reported -$57.39M of net income.